Guo Y, Li T, Yang X, Qi Z, Chen L, Huang S
Department of Radiology of Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China.
Guangzhou Xinhua College, Guangzhou 510520, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jun 20;43(6):1035-1040. doi: 10.12122/j.issn.1673-4254.2023.06.21.
To identify the problems in clinical radiotherapy planning for cervical cancer through quantitative evaluation of the radiotherapy plans to improve the quality of the plans and the radiotherapy process.
We selected the clinically approved and administered radiotherapy plans for 227 cervical cancer patients undergoing external radiotherapy at Sun Yat-sen University Cancer Center from May, 2019 to January, 2022. These plans were transferred from the treatment planning system to the Plan IQ workstation. The plan quality metrics were determined based on the guidelines of ICRU83 report, the GEC-ESTRO Working Group, and the clinical requirements of our center and were approved by a senior clinician. The problems in the radiotherapy plans were summarized and documented, and those with low scores were re-planned and the differences were analyzed.
We identified several problems in the 277 plans by quantitative evaluation. Inappropriate target volume selection (with scores < 60) in terms of GTV, PGTV (CI) and PGTV (V) was found in 10.6%, 65.2%, and 1% of the plans, respectively; and the PGTV (CI), GTV, and PCTV (D, HI) had a score of 0 in 0.4%, 10.1%, 0.4%, 0.4% of the plans, respectively. The problems in the organs at risk (OARs) involved mainly the intestines (the rectum, small intestine, and colon), found in 20.7% of the plans, and in occasional cases, the rectum, small intestine, colon, kidney, and the femoral head had a score of 0. Senior planners showed significantly better performance than junior planners in PGTV (V, D), PCTV (CI), and CTV (D) (≤0.046) especially in terms of spinal cord and small intestine protection (≤0.034). The bowel (the rectum, small intestine and colon) dose was significantly lower in the prone plans than supine plans ( < 0.05), and targets coverage all met clinical requirements. Twenty radiotherapy plans with low scores were selected for re-planning. The re-planned plans had significantly higher GTV (D) and PTV (V, D) ( < 0.05) with significantly reduced doses of the small intestines (V V), the colon (V V), and the bladder (D) ( < 0.05).
Quantitative evaluation of the radiotherapy plans can not only improve the quality of radiotherapy plan, but also facilitate risk management of the radiotherapy process.
通过对宫颈癌放射治疗计划进行定量评估,找出临床放射治疗计划中存在的问题,以提高计划质量和放射治疗过程的质量。
我们选取了2019年5月至2022年1月在中山大学肿瘤防治中心接受体外放射治疗的227例宫颈癌患者的临床批准并实施的放射治疗计划。这些计划从治疗计划系统传输至Plan IQ工作站。根据ICRU83报告、GEC-ESTRO工作组的指南以及我们中心的临床要求确定计划质量指标,并经一位资深临床医生批准。总结并记录放射治疗计划中的问题,对得分低的计划重新规划并分析差异。
通过定量评估,我们在277个计划中发现了几个问题。分别有10.6%、65.2%和1%的计划在GTV、PGTV(CI)和PGTV(V)方面存在靶区体积选择不当(得分<60)的情况;分别有0.4%、10.1%、0.4%和0.4%的计划中PGTV(CI)、GTV和PCTV(D, HI)得分为0。危及器官(OARs)的问题主要涉及肠道(直肠、小肠和结肠),在20.7%的计划中发现,偶尔也有直肠、小肠、结肠、肾脏和股骨头得分为0的情况。资深计划者在PGTV(V, D)、PCTV(CI)和CTV(D)方面的表现明显优于初级计划者(≤0.046),尤其是在脊髓和小肠保护方面(≤0.03)。俯卧位计划中的肠道(直肠、小肠和结肠)剂量明显低于仰卧位计划(<0.05),靶区覆盖均符合临床要求。选取20个低分放射治疗计划进行重新规划。重新规划后的计划中GTV(D)和PTV(V, D)明显更高(<0.05),小肠(V V)、结肠(V V)和膀胱(D)的剂量明显降低(<0.05)。
放射治疗计划的定量评估不仅可以提高放射治疗计划的质量,还有助于放射治疗过程的风险管理。